Kim Carlos Plus SideZ Podcast
banner
dmfkimonmounjaro.bsky.social
Kim Carlos Plus SideZ Podcast
@dmfkimonmounjaro.bsky.social
Speaker | GLP-1 Obesity Care Advocate | Podcast Host & Producer | Marketing Strategist | #GLP1Community
If you’re new to taking a glp1 to treat obesity or type 2 diabetes, here are some tips. Follow The Plus SideZ Podcast anywhere you get your podcasts #glp1 #zepbound #wegovy
August 13, 2025 at 1:42 AM
Reposted by Kim Carlos Plus SideZ Podcast
Thank you to The Plus SideZ podcast for having me on to talk about the patent system and how the pharma industry’s abuse of it keeps GLP-1 prices so high.
July 16, 2025 at 5:28 PM
A special thanks to Tahir Amin for joining The Plus SideZ Podcast to explain how the patent system affects the price of GLP-1s. Education is power! #glp1 @mcuban.bsky.social
Thank you to The Plus SideZ podcast for having me on to talk about the patent system and how the pharma industry’s abuse of it keeps GLP-1 prices so high.
July 16, 2025 at 8:20 PM
Can’t help wonder why TikTok wouldn’t take a 20B payday and sell the US app without the algorithm. Maybe to spite the US after all? Is there something to this national security Trojan horse? #tiktokban #scotus
January 10, 2025 at 5:02 AM
Ok…what are we thinking about a hack from China & the TikTok ban. Connected? #tiktokban #glp1community

www.bbc.com/news/article...
US Treasury says it was hacked by China in 'major incident'
A Chinese state-sponsored hacker broke into the US Treasury Department's systems and accessed some unclassified documents.
www.bbc.com
January 1, 2025 at 6:20 AM
Why choose expensive, scarce meds like Ozempic if obesity is just about appetite suppression? GLP-1s treat the biological dysfunction behind obesity, not just hunger. Let’s end the shame. Listen to The Plus SideZ Podcast. youtu.be/dzffLlGwH8c?...
FDA Says Popular ‘Weight Loss Meds’ No Longer in Shortage: What Patients Need to Know
YouTube video by The Plus SideZ: Cracking the Obesity Code
youtu.be
December 24, 2024 at 4:00 PM
🚨 The FDA ends the tirzepatide shortage, giving compounding pharmacies 60-90 days to stop production. What does this mean for patients? CEO of the Alliance for Pharmacy Compounding breaks down the impact and the role of PBM reform. youtu.be/dzffLlGwH8c?...

👉 lnkd.in/e-XUTU3d

#CompoundGLP1
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
December 21, 2024 at 5:30 PM
The FDA resolved the tirzepatide shortage, giving compounders 60-90 days to stop making unbranded versions. What does this mean for access, affordability & GLP-1 meds like Zepbound? We're talking with Scott Brunner, CEO of the Alliance for Pharmacy Compounding, on The Plus SideZ Podcast! #glp1
December 20, 2024 at 12:39 AM
First time posting. Excited to see what Bluesky can do for connecting the GLP1 Community. #glp1community
December 14, 2024 at 1:41 PM